Patients with COVID-19: in the dark-NETs of neutrophils
SARS-CoV-2 infection poses a major threat to the lungs and multiple other organs,
occasionally causing death. Until effective vaccines are developed to curb the pandemic, it …
occasionally causing death. Until effective vaccines are developed to curb the pandemic, it …
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP … - New England Journal …, 2021 - Mass Medical Soc
Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label …
RD Lopes, RHM Furtado, AVS Macedo, B Bronhara… - The Lancet, 2021 - thelancet.com
Background COVID-19 is associated with a prothrombotic state leading to adverse clinical
outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised …
outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised …
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high
prevalence and easy transmission, which is expanding globally with no conventional …
prevalence and easy transmission, which is expanding globally with no conventional …
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
G Lisco, A De Tullio, E Jirillo, VA Giagulli… - Journal of …, 2021 - Springer
Background Thyroid dysfunction has been observed in patients with COVID-19, and
endocrinologists are requested to understand this clinical issue. Pandemic-related …
endocrinologists are requested to understand this clinical issue. Pandemic-related …
Potential relationships between COVID-19 and the thyroid gland: an update
R Naguib - Journal of International Medical Research, 2022 - journals.sagepub.com
In this review, I aim to provide a complete overview of recent advances in knowledge
regarding severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)-induced thyroid …
regarding severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)-induced thyroid …
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
M Levi, T Iba - Internal and emergency medicine, 2021 - Springer
One of the significant complications of severe COVID-19 infections is a coagulopathy that
seems to be related to the occurrence of venous and arterial thromboembolic disease. The …
seems to be related to the occurrence of venous and arterial thromboembolic disease. The …
The cytokine storm and thyroid hormone changes in COVID-19
L Croce, D Gangemi, G Ancona, F Liboà… - Journal of …, 2021 - Springer
Background COVID-19 is now a worldwide pandemic. Among the many extra-pulmonary
manifestations of COVID-19, recent evidence suggested a possible occurrence of thyroid …
manifestations of COVID-19, recent evidence suggested a possible occurrence of thyroid …
Increased plasma heparanase activity in COVID-19 patients
B Buijsers, C Yanginlar, A de Nooijer… - Frontiers in …, 2020 - frontiersin.org
Reports suggest a role of endothelial dysfunction and loss of endothelial barrier function in
COVID-19. It is well established that the endothelial glycocalyx-degrading enzyme …
COVID-19. It is well established that the endothelial glycocalyx-degrading enzyme …